Deal News

  • 14 June 2019

    Orchestra BioMed licenses Virtue SEB to Terumo

    Orchestra BioMed has entered a deal providing exclusive worldwide development and commercialisation rights for its Virtue Sirolimus-Eluting Balloon (SEB) to Japanese medical devices maker Terumo.

Close
Close
Close

Go Top